ZRSR2 and chronic myelomonocytic leukemia: Finally, for comparison, in the analysed articles, around 33% of chronic myelomonocytic leukemia (CMML) patients harbored SRSF2 mutations [42,68]; 8% U2AF1 mutations, 9% ZRSR2 mutations [42] and 5%, SF3B1 mutations [42,65].